MIAMI, March 29, 2025 /PRNewswire/ — The Law Offices of Jason Turchin, a national personal injury firm, is educating Florida residents on how medical malpractice cases work in the state. Victims of negligent medical care may be entitled to compensation, but Florida has strict laws that can make these cases complex.
“Medical malpractice cases in Florida often require experience and a deep understanding of the law,” says Jason Turchin, Esq., a personal injury attorney who has handled numerous malpractice claims. “Victims generally deserve answers and justice when medical care goes wrong.”
What Is Medical Malpractice in Florida?
Medical malpractice occurs when a healthcare provider fails to meet the standard of care, resulting in injury or death. This may include:
Florida‘s Pre-Suit Requirements
Florida law generally requires a specific pre-suit process before a medical malpractice lawsuit can be filed:
Time Limits to File a Claim
Florida has a two-year statute of limitations, meaning victims generally have two years from the date they knew or should have known about the malpractice. There are some exceptions, such as fraud or cases involving minors.
Potential Compensation
Medical malpractice victims may be entitled to compensation for:
Call the Law Offices of Jason Turchin
If you or a loved one suffered due to possible medical malpractice in Florida, contact the Law Offices of Jason Turchin for a free consultation at (800) 337-7755 or visit www.jasonturchin.com.
About the Law Offices of Jason Turchin
The firm represents victims of personal injury and wrongful death throughout Florida and the U.S. Jason Turchin, Esq. has been featured in CBS Evening News, Forbes, and Rolling Stone for his work in consumer and injury law.
SOURCE Law Offices of Jason Turchin
– Pharmacology modeling data presented at the European Academy of Allergy & Clinical Immunology (EAACI)…
D-bal-max D-Bal MAX Glasgow, June 15, 2025 (GLOBE NEWSWIRE) -- In the quest for enhanced…
Media ReleaseCOPENHAGEN, Denmark; June 15, 2025 Results from the EPCORE® NHL-2 trial show investigational treatment…
Results from the Phase 2 RedirecTT-1 study demonstrate deep responses with 78.9 percent overall response…
After a thorough clinical review, the benefit-risk for the use of Elevidys in non-ambulatory patients…
77% of patients (150 mg Q4W) treated with barzolvolimab who had angioedema at baseline were…